Posted by Michael Wonder on 21 Sep 2022
The Inflation Reduction Act aims to lower drug costs — but here’s how big pharma could get around it
21 September 2022 - The tactics may ultimately threaten the law’s ability to lower drug costs for many in the US.
The law takes aim at insulin costs, caps out of pocket spending for Medicare beneficiaries, and allows the federal government to negotiate prices on the costliest prescription drugs. It also will require drug makers to pay a rebate to Medicare if they raise prices too sharply.
